211. 左心低形成症候群 Hypoplastic left heart syndrome Clinical trials / Disease details

臨床試験数 : 22 / 薬物数 : 29 - (DrugBank : 9) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 14

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03779711 (ClinicalTrials.gov)	June 6, 2019	4/12/2018	Intramyocardial Injection of Autologous Umbilical Cord BloodDerived Mononuclear Cells During Surgica ...	Phase IIb Study of Intramyocardial Injection of Autologous Umbilical Cord BloodDerived Mononuclear C ...	Hypoplastic Left Heart Syndrome	Biological: Autologous (self) mononuclear cells derived from umbilical cord blood;Procedure: Stage I ...	Timothy J Nelson, MD, PhD	University of Oklahoma;Children's Hospital of Philadelphia;Children's Hospital Los Angeles;Children' ...	Active, not recruiting	N/A	12 Months	All	95	Phase 2	United States
2	NCT01883076 (ClinicalTrials.gov)	May 15, 2013	11/6/2013	Safety Study of Autologous Umbilical Cord BloodCells for Treatment of Hypoplastic Left Heart Syndrom ...	Phase I Safety Study of Autologous Umbilical Cord BloodDerived Mononuclear Cells During Surgical Sta ...	Hypoplastic Left Heart Syndrome	Biological: autologous cell-based delivery	Timothy J Nelson, MD, PhD	University of Oklahoma;Children's Hospital of Philadelphia;Children's Hospitals and Clinics of Minne ...	Completed	N/A	18 Months	All	30	Phase 1	United States
3	NCT01445041 (ClinicalTrials.gov)	September 1, 2011	15/9/2011	Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart S ...	Autologous Cord Blood Cells for Patients With HLHS: Phase I Study of Feasibility and Safety	Hypoplastic Left Heart Syndrome	Biological: Autologous Umbilical Cord Blood	Michael Cotten	NULL	Terminated	N/A	2 Days	All	7	Phase 1	United States

First Previous1Next Last